<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22299" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Glottic Cancer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williamson</surname>
            <given-names>Andrew J.</given-names>
          </name>
          <aff>Imperial College London</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bondje</surname>
            <given-names>Sophie</given-names>
          </name>
          <aff>Lister Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Williamson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sophie Bondje declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22299.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Laryngeal cancers are one of the most common head and neck malignancies. Glottic cancers arise from true vocal cords and similarly to other laryngeal cancers linked with poorer outcomes to smoking and alcohol abuse. Management and involvement of a multi-disciplinary team can vary depending on the stage of the disease. This activity outlines the etiology, clinical history, and prognosis of glottic cancer, and highlights the role of the interprofessional healthcare team in investigating and managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of glottic cancer with related medical conditions and emergencies.</p></list-item><list-item><p>Describe the appropriate evaluation of glottic cancer.</p></list-item><list-item><p>Review the management options available for glottic cancer.</p></list-item><list-item><p>Summarize the interprofessional team strategies for improving care coordination and communication to advance Glottic cancer and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22299&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22299">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22299.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Laryngeal cancers are one of the most common head and neck malignancies and thought to make up 1% of all cancers worldwide. Glottic cancer is defined as a malignancy arising from the true vocal cords and the anterior and posterior commissure of the larynx. Like other laryngeal cancers, smoking and alcohol abuse typically causes glottic cancer; however, tumors from this subsite have a better prognosis than other laryngeal cancers due to its reduced rate of local, nodal and distant invasion. The management of glottic cancers can vary significantly, from single modality transoral laser surgery or radiotherapy in early disease, through to chemoradiotherapy or total laryngectomy for more advanced disease. Providers, therefore, must have a thorough understanding of the anatomy and staging of glottic cancer to facilitate the most appropriate management plan for this disease.</p>
      </sec>
      <sec id="article-22299.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There has long been an association between the consumption of smoking and excessive alcohol consumption and the occurrence of glottic and laryngeal squamous cell carcinoma. Rates of laryngeal cancer are 15-30 times higher in smokers than non-smokers<xref ref-type="bibr" rid="article-22299.r1">[1]</xref>, with the inclusion of heavy alcohol intake having a multiplicative effect on the risk of malignancy.<xref ref-type="bibr" rid="article-22299.r2">[2]</xref>&#x000a0;Moreover, continued smoking following diagnosis and treatment is associated with&#x000a0;poorer&#x000a0;survival outcomes and a higher rate of recurrence.<xref ref-type="bibr" rid="article-22299.r3">[3]</xref>&#x000a0;</p>
        <p>Other proposed risk factors include gastroesophageal reflux, low socioeconomic status, opium use, red meat, and occupational exposure, with a healthy diet thought to have a minor protective effect.<xref ref-type="bibr" rid="article-22299.r4">[4]</xref><xref ref-type="bibr" rid="article-22299.r5">[5]</xref><xref ref-type="bibr" rid="article-22299.r6">[6]</xref><xref ref-type="bibr" rid="article-22299.r7">[7]</xref><xref ref-type="bibr" rid="article-22299.r8">[8]</xref><xref ref-type="bibr" rid="article-22299.r9">[9]</xref>&#x000a0;Although the role of human papillomavirus (HPV) is now well established in many oropharyngeal tumors,&#x000a0;this is less clear in laryngeal cancers. Several meta-analyses have suggested approximately 20-30% of laryngeal cancers may be associated with HPV. However, these rates vary considerably with geographical location, and further studies will be needed to establish a true causal link between the virus and glottic cancer.<xref ref-type="bibr" rid="article-22299.r10">[10]</xref><xref ref-type="bibr" rid="article-22299.r11">[11]</xref></p>
      </sec>
      <sec id="article-22299.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Primary laryngeal and glottic cancers are uncommon, representing approximately 1% of all male and 0.3% of female cancers worldwide. The American Cancer Society estimates&#x000a0;the diagnosis of 12370 new cases of laryngeal carcinoma in 2020, with approximately 60% arising primarily from the glottis. Of these new cases, 9820 will occur in men, and&#x000a0;3750 will die from the disease with a male&#x000a0;to female ratio of 4&#x000a0;to 1. Reassuringly, these figures&#x000a0;follow&#x000a0;a 2&#x000a0;to 3% year on year reduction in overall cases. Rates of laryngeal cancer vary significantly with specific patient characteristics as male, low-income, and African-American patients have shown to present with&#x000a0;higher rates of advanced disease.<xref ref-type="bibr" rid="article-22299.r12">[12]</xref><xref ref-type="bibr" rid="article-22299.r13">[13]</xref>&#x000a0;Moreover, geographical location can influence rates of disease, with England exhibiting less than half the number of cases per 100,000 compared to Scotland and Northern Ireland (2 vs. 4.2 vs. 4.3).</p>
      </sec>
      <sec id="article-22299.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Squamous cell carcinoma composes over 90% of all laryngeal malignancies. It is slow-growing and can appear as an exophytic or endophytic lesion.&#x000a0;Glottic tumors typically arise from the free margin of the anterior 1/3rd of the vocal cords. Numerous anatomical boundaries can contain&#x000a0;the lesion within the Reinke space for a significant period.&#x000a0;Spread may occur locally across the anterior commissure (although the anterior commissure ligament provides a resilient barrier to the invasion) or posteriorly to the arytenoid cartilages.</p>
        <p>Cancers may eventually breach the glottis&#x000a0;through a direct invasion of the vocal ligament and vocalis muscles, causing vocal cord fixation via involvement of the thyroarytenoid muscle. From here, tumors gain access to the paraglottic space, facilitating cranial and caudal spread. Laryngeal cartilage is relatively resistant to direct tumor invasion, although invasion of the thyroid cartilage will often occur in advanced T4a disease. While supraglottic cancers often exhibit early bilateral nodal metastasis and subglottic cancers invade paratracheal and mediastinal nodes, carcinomas of the glottis have a low rate of lymphatic spread, attributed to an inadequate submucosal lymphatic supply. Nodal metastasis tends to occur when the tumor breaches the anterior commissure or invades another laryngeal subsite, most often spreading to levels 2, 3, 4, and 6.</p>
        <p>Lymphoma is the second most common laryngeal malignancy;&#x000a0;however, only thought to represent less than 1% of all cancers in this region. Nevertheless, it remains an important differential diagnosis, as it rarely requires surgical intervention beyond initial biopsy or tracheostomy in acute airway obstruction. It has&#x000a0;a good prognosis when managed with chemoradiotherapy.<xref ref-type="bibr" rid="article-22299.r14">[14]</xref><xref ref-type="bibr" rid="article-22299.r15">[15]</xref>&#x000a0;Other laryngeal cancer subtypes can arise from a large variety of cells, including chondrosarcoma, neuroendocrine tumors, and salivary gland cell type cancers; however, these tumors are vanishingly rare and are described only in a limited number of case reports and case series.<xref ref-type="bibr" rid="article-22299.r16">[16]</xref><xref ref-type="bibr" rid="article-22299.r17">[17]</xref><xref ref-type="bibr" rid="article-22299.r18">[18]</xref></p>
      </sec>
      <sec id="article-22299.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Glottic cancers often present early, as even small lesions of the glottis can result in significant hoarseness. Resultantly, current American and British guidelines advise urgent referral to an otolaryngologist&#x000a0;for persistent&#x000a0;hoarseness lasting 4&#x000a0;and 6 weeks, respectively. However, there have been suggestions for referrals as early as three weeks from the onset of hoarseness.<xref ref-type="bibr" rid="article-22299.r19">[19]</xref><xref ref-type="bibr" rid="article-22299.r20">[20]</xref>&#x000a0;Patients may also present with other head and neck red flag symptoms, including dysphagia, odynophagia, and referred otalgia. Though this typically occurs in advanced disease with tumor extension beyond the glottis. In more extreme cases, patients can present late as an emergency with stridor and acute airway compromise. Looking at the patient's past medical and drug history should be done to ascertain associated risk factors and assess the patient's fitness for oncological treatment or major surgery. Quantification of etiological risk factors, in particular, smoking and alcohol&#x000a0;consumption status, must also be performed.</p>
        <p>Patients require a full ear, nose, and throat examination by an experienced otolaryngologist,&#x000a0;including palpation of the neck for cervical lymphadenopathy, as well as close inspection of the oral cavity and oropharynx to exclude an oropharyngeal malignancy and assess dentition. Flexible nasal endoscopy in the outpatient clinic is essential to evaluate the glottis with particular attention paid to the involvement of one or more cords, cord mobility, and invasion to other subsites in the supraglottis and subglottis. To assess subtle vocal cord immobility, video-stroboscopic equipment is available.</p>
      </sec>
      <sec id="article-22299.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The initial investigation of choice for glottic cancer is a CT scan of neck and thorax to accurately assess local invasion, nodal disease, and distant metastasis. However, CT scans are unlikely to be of any diagnostic benefit in early T1 cancers that do not involve the anterior commissure, as both local and nodal disease in these cancers is exceedingly uncommon.<xref ref-type="bibr" rid="article-22299.r21">[21]</xref>&#x000a0;MRI scanning can offer superior soft tissue definition in the neck and thus used in some centers for assessment of direct invasion of the laryngeal cartilages.<xref ref-type="bibr" rid="article-22299.r22">[22]</xref>&#x000a0;PET-CT may be of use when the primary site is not detectable, and a 12-week post-treatment PET-CT is the current gold standard method of assessing response to treatment.<xref ref-type="bibr" rid="article-22299.r23">[23]</xref>&#x000a0;While considering patients for radiotherapy, the indication of an x-ray orthopantomogram is essential to&#x000a0;reduce the risk of highly debilitating osteoradionecrosis.<xref ref-type="bibr" rid="article-22299.r24">[24]</xref></p>
        <p>A definitive diagnosis is achieved with direct laryngoscopy and biopsy under general anesthetic. Assessment with 0, 30, and 70-degree&#x000a0;rigid endoscopes can provide the most detailed evaluation of the primary tumor and its extension to other laryngeal subsites.</p>
      </sec>
      <sec id="article-22299.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Early T1-T2a Glottic Cancers</bold>
</p>
        <p>Given the low incidence of nodal metastasis and the small, slow-growing nature of the primary lesion, early T1-2 glottic cancers can be&#x000a0;managed very successfully with single-modality treatment. Transoral laser microsurgery (TLM) and radiotherapy are the most commonly employed treatments for early glottic cancer. Although there is no direct comparison in a randomized controlled trial, a&#x000a0;Cochrane review has noted equivalent survival outcomes and local disease control in both methods.<xref ref-type="bibr" rid="article-22299.r25">[25]</xref>&#x000a0;Resultantly, the use of a particular method is often determined by tumor anatomy and resectability, perceived functional outcomes, patient preference, and departmental experience.</p>
        <p>The fundamental principles of transoral laser microsurgery are the preservation of the cricoid cartilage and of at least a single crico-arytenoid joint, failure of which can result in a narrowed airway and a non-functional larynx respectively.<xref ref-type="bibr" rid="article-22299.r26">[26]</xref>&#x000a0;TLM&#x000a0;is a day case done under general anesthesia with a CO2 laser. Risks of complications are low, and it avoids the morbidity, and repeated outpatient visits seen in radiotherapy, while also reserving&#x000a0;radiotherapy&#x000a0;as a second-line option should the tumor recur.<xref ref-type="bibr" rid="article-22299.r27">[27]</xref>&#x000a0;It has been well established that a 2 mm surgical margin must be achieved to ensure complete oncological resection.<xref ref-type="bibr" rid="article-22299.r28">[28]</xref>&#x000a0;This may prove to be technically challenging in bulky tumors, and risk causing poor voice outcomes&#x000a0;secondary to laryngeal&#x000a0;scarring in anterior commissure lesions. Resultantly, radiotherapy may be preferable in T1b-T2 lesions involving the anterior commissure and patients&#x000a0;unsuitable for&#x000a0;an endoscopic approach (e.g., restricted c-spine movement).<xref ref-type="bibr" rid="article-22299.r27">[27]</xref><xref ref-type="bibr" rid="article-22299.r29">[29]</xref></p>
        <p>Radiotherapy regimes for glottic cancers vary between centers. Usually, they range from&#x000a0;50&#x02013;52 Gy&#x000a0;in 16 fractions&#x000a0;or 53&#x02013;55 Gy in 20 fractions over three to four weeks, with&#x000a0;a higher dose per fraction resulting in improved locoregional control&#x000a0;for both T1 and T2 lesions.<xref ref-type="bibr" rid="article-22299.r30">[30]</xref><xref ref-type="bibr" rid="article-22299.r31">[31]</xref>&#x000a0;In tumors involving the anterior commissure, augmentation of radiotherapy beams is essential to provide a bolus of radiation to the anterior neck, as this is a&#x000a0;frequent site of post-treatment recurrence.<xref ref-type="bibr" rid="article-22299.r32">[32]</xref>&#x000a0;Unlike early to moderately advanced supraglottic cancers, there is no routine need for bilateral nodal irradiation for early glottic cancer. Although somewhat limited due to short-term radiation toxicity side effects, radiotherapy is said to have superior voice-related outcomes when compared to TLM.<xref ref-type="bibr" rid="article-22299.r33">[33]</xref></p>
        <p>Partial laryngectomy is less commonly performed for primary early glottic cancers but offers a viable alternative to radiotherapy and TLM in experienced centers.&#x000a0;Systematic reviews have demonstrated comparable oncological outcomes in both de novo and radio-recurrent cancers to radiotherapy and TLM.<xref ref-type="bibr" rid="article-22299.r34">[34]</xref><xref ref-type="bibr" rid="article-22299.r35">[35]</xref>&#x000a0;However, appropriate patient selection is vital to achieving surgical clearance, as specific tumor characteristics such as subglottic or posterior commissure extension, cricoarytenoid complex&#x000a0;fixation, or significant thyroid cartilage invasion are not appropriate candidates for partial laryngectomy.<xref ref-type="bibr" rid="article-22299.r36">[36]</xref></p>
        <p>
<bold>Moderately Advanced T2b-T3 Glottic Cancers</bold>
</p>
        <p>At present, UK and US guidelines advise organ preservation therapy for moderately advanced glottic cancer in the form of chemoradiotherapy.<xref ref-type="bibr" rid="article-22299.r27">[27]</xref><xref ref-type="bibr" rid="article-22299.r29">[29]</xref>&#x000a0;Before the early 1990s, however, the treatment of choice for moderately advanced glottic cancer was total laryngectomy. The Veterans Affairs (VALCSG) study resulted in a paradigm shift in the management of these cancers, as they found equivalent two-year survival of induction chemotherapy and radiotherapy (68%) compared to laryngectomy and radiotherapy (64%), with a lower rate of salvage laryngectomy noted in T3 patients.<xref ref-type="bibr" rid="article-22299.r37">[37]</xref>&#x000a0;As a result, the management of moderately advanced glottic cancers now focuses on laryngeal preservation therapies, wherein radiotherapy and chemotherapy are employed to avoid the significant lifestyle change and long term morbidity associated with a laryngectomy. The RTOG 91-11 trial further built on this, establishing that concurrent platinum-based chemotherapy (cisplatin) with radiotherapy had higher 3-year survival compared to induction chemotherapy with radiotherapy or radiotherapy alone.<xref ref-type="bibr" rid="article-22299.r38">[38]</xref></p>
        <p>Furthermore, a 10-year follow-up study confirmed the long term survival benefits of the concurrent chemotherapy group but did note a higher rate of non-cancer deaths in this treatment arm.<xref ref-type="bibr" rid="article-22299.r39">[39]</xref>&#x000a0;The addition of chemotherapy, however, can cause significant side effects with a severe impact on the patients' quality of life. This impact, combined with the reducing efficacy of chemotherapy in patients over the age of 70, means it is not routinely used in elderly patients with head and neck cancers.</p>
        <p>
<bold>Advanced T4 Glottic Cancer</bold>
</p>
        <p>Chemoradiotherapy may be used effectively in some advanced T4 cancers; however, the high rate of the thyroid cartilage and neck soft tissue invasion means many patients will be unsuitable for laryngeal preservation and&#x000a0;will require surgery in the form of total laryngectomy. The Veterans affairs study noted T4 laryngeal tumors had a reduced response to chemotherapy and a higher rate of salvage surgery, suggesting organ preservation is not effective in advanced laryngeal cancer.<xref ref-type="bibr" rid="article-22299.r37">[37]</xref>&#x000a0;Additionally, epidemiological studies have shown improved survival&#x000a0;in patients with locally advanced cancers undergoing total laryngectomy compared to chemoradiotherapy,&#x000a0;strongly suggesting surgery is the treatment of choice for T4a glottic disease.<xref ref-type="bibr" rid="article-22299.r40">[40]</xref><xref ref-type="bibr" rid="article-22299.r41">[41]</xref> Total laryngectomy may also be considered in patients with significant laryngeal destruction, pre-laryngectomy tracheostomy, and non-functioning larynges.<xref ref-type="bibr" rid="article-22299.r29">[29]</xref>&#x000a0;T4b tumors are deemed inoperable due to the encasement of major vessels or the inability to achieve negative margins. Consideration of palliative treatment or chemoradiotherapy at this stage is feasible, and this has shown an association with a reduction of tumor progression and improved life expectancy.</p>
        <p>
<bold>Postoperative Treatment</bold>
</p>
        <p>Postoperative radiotherapy can improve locoregional outcomes in advanced head and neck cancer, and is therefore recommended in any T4 tumors, T2-3 lesions with significant nodal disease, and any patient with positive margins or extra-nodal extension.<xref ref-type="bibr" rid="article-22299.r42">[42]</xref>&#x000a0;The EORTC 22931 trial found that the addition of concurrent postoperative chemotherapy may further improve locoregional control and disease-free survival compared to radiotherapy alone.<xref ref-type="bibr" rid="article-22299.r42">[42]</xref>&#x000a0;RTOG 95-11 trial noted similar results in high-risk patients, but this stated a higher morbidity burden in the chemotherapy group. Thus postoperative chemotherapy&#x000a0;may be used selectively in patients&#x000a0;with a high risk of recurrence.<xref ref-type="bibr" rid="article-22299.r43">[43]</xref></p>
        <p>
<bold>Treatment of Nodal Disease</bold>
</p>
        <p>The rate of nodal disease in glottic cancer is considerably lower than the supraglottic disease, where bilateral elective neck dissection or nodal irradiation is advised even in clinically N0 necks.<xref ref-type="bibr" rid="article-22299.r44">[44]</xref>&#x000a0;Nevertheless, treatment with&#x000a0;chemoradiotherapy&#x000a0;has an&#x000a0;excellent&#x000a0;complete response rate in&#x000a0;N1-3 disease,&#x000a0;and many patients with advanced T3/4 glottic cancer will undergo ipsilateral or bilateral level 2-5 radiotherapy, regardless of pre-treatment nodal status.<xref ref-type="bibr" rid="article-22299.r45">[45]</xref><xref ref-type="bibr" rid="article-22299.r46">[46]</xref></p>
        <p>In patients undergoing total laryngectomy, elective bilateral neck dissection for staging purposes is essential, which may prevent the need for postoperative radiotherapy if no positive nodes are present. In patients who have failed to show a complete response following completion of treatment,&#x000a0;or before chemoradiotherapy in patients with significant volume neck disease that&#x000a0;are less likely to respond to&#x000a0;primary oncological treatment, neck dissection is considered.<xref ref-type="bibr" rid="article-22299.r47">[47]</xref></p>
      </sec>
      <sec id="article-22299.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of glottic cancer includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Supraglottic, subglottic and transglottic laryngeal cancers</p>
          </list-item>
          <list-item>
            <p>Other head and neck cancers, including hypopharyngeal and upper esophageal</p>
          </list-item>
          <list-item>
            <p>Pre-malignant glottic lesions (leukoplakia, low and high-grade dysplasia)</p>
          </list-item>
          <list-item>
            <p>Vocal cord immobility</p>
          </list-item>
          <list-item>
            <p>Benign laryngeal lesions&#x000a0;such as laryngeal papillomatosis, Reinke edema, vocal cord polyps, cysts, and nodules, granuloma, chronic laryngitis, hyperkeratosis, and functional dysphonia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22299.s10" sec-type="Staging">
        <title>Staging</title>
        <p>The staging of glottic and other laryngeal cancers is according to the 2016 eighth edition of the AJCC TNM classification of malignant tumors. Unlike oral and oropharyngeal cancers, depth of invasion and p16 status does not have a role in staging glottic tumors. The extra-nodal extension is one of the most important predictors of clinical outcomes in head and neck cancers. To reflect this, TNM8 introduced the presence of extra-nodal extension into all laryngeal cancer staging, with its presence immediately classifying a patient as N3b regardless of nodal size, quantity, or location; to accurately reflect the negative impact this finding can have on prognosis.<xref ref-type="bibr" rid="article-22299.r48">[48]</xref></p>
        <p>The TMN8 Tumour (T) staging is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tx: primary tumor cannot be assessed</p>
          </list-item>
          <list-item>
            <p>Tis: carcinoma in situ</p>
          </list-item>
          <list-item>
            <p>T1: tumor limited to the vocal cords (including the anterior and posterior commissure) with normal mobility
<list list-type="bullet"><list-item><p>T1a: tumor limited to one vocal cord</p></list-item><list-item><p>T1b: tumor involving both vocal cords</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>T2:
<list list-type="bullet"><list-item><p>T2a: tumor extends to supraglottis and/or subglottis with normal vocal fold mobility</p></list-item><list-item><p>T2b: tumor extends to the supraglottis and/or subglottis, or with impaired vocal cord mobility</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>T3: tumor limited to the larynx with vocal cord fixation or invasion of the paraglottic space or inner cortex of the thyroid cartilage</p>
          </list-item>
          <list-item>
            <p>T4: advanced disease
<list list-type="bullet"><list-item><p>T4a: tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (trachea, cricoid cartilage, tongue muscles, strap muscles, thyroid, or esophagus)</p></list-item><list-item><p>T4b: tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The TNM 8 nodal (N) staging is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nx: nodes unable to be assessed</p>
          </list-item>
          <list-item>
            <p>N0: no regional lymph nodes</p>
          </list-item>
          <list-item>
            <p>N1: single ipsilateral lymph node &#x02264;3cm and no extra-nodal extension</p>
          </list-item>
          <list-item>
            <p>N2
<list list-type="bullet"><list-item><p>N2a: single ipsilateral lymph node &#x0003e;3cm but &#x0003c;6 cm in greatest dimension and no&#x000a0;extra-nodal extension</p></list-item><list-item><p>N2b: multiple ipsilateral lymph nodes, none &#x0003e;6cm in greatest dimension and no extra-nodal extension</p></list-item><list-item><p>N2c: bilateral or contralateral lymph nodes, none &#x0003e;6cm in greatest dimension and&#x000a0;extra-nodal extension</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>N3
<list list-type="bullet"><list-item><p>N3a: any lymph node &#x0003e;6cm and&#x000a0;no-extra-nodal extension</p></list-item><list-item><p>N3b: any nodes&#x000a0;with clinically overt extra-nodal extension</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The TNM8 metastasis (M) staging is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>M0: no distant metastasis</p>
          </list-item>
          <list-item>
            <p>M1: distant metastasis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22299.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Overall, early laryngeal cancer carries a good prognosis, with 5-year survival outcomes, approximately 90% for stage 1 and 80% for stage 2 cancers when managed with single modality radiotherapy or laryngeal preserving surgery.<xref ref-type="bibr" rid="article-22299.r49">[49]</xref>&#x000a0;Survival outcomes are poorer for more advanced disease, with the 1990 Veterans Affairs study noting a 2-year survival of 68% and 64% for advanced disease treated with primary radiotherapy together with induction chemotherapy versus laryngectomy and postoperative radiotherapy.<xref ref-type="bibr" rid="article-22299.r37">[37]</xref>&#x000a0;Glottis cancer, however, carries a&#x000a0;slightly better overall&#x000a0;prognosis&#x000a0;than other laryngeal sites, with 5-year survival rates of 83% for localized, 42% for advanced and 76% for all stages of the disease, compared to&#x000a0;61%, 30%, and 46% for supraglottic and&#x000a0;60%, 45%,&#x000a0;and 52% for subglottic cancers, respectively. Unfortunately, between 1977 and 2002, the overall 5-year survival for regional and distant glottic cancer has fallen.<xref ref-type="bibr" rid="article-22299.r50">[50]</xref></p>
      </sec>
      <sec id="article-22299.s12" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Complications of Glottic Cancer</bold>
</p>
        <p>Compared to other laryngeal cancers, glottic cancer has a reduced propensity for regional and distant spread, but may still cause significant complications when left untreated. Dysphonia may occur&#x000a0;through the direct invasion of the thyroarytenoid muscle and vocal ligament, progressing to dyspnoea, aspiration pneumonia, stridor, and acute airway emergencies necessitating tracheostomy in severe cases. Invasion of adjacent structures in the larynx and pharynx may also result in dysphagia and weight loss&#x000a0;requiring nasogastric or gastrostomy feeding. The advanced local disease may encase and erode into the internal jugular vein and carotid artery, with the latter resulting in a carotid blowout and fatal hemorrhage.</p>
        <p>
<bold>Complications of Chemoradiotherapy</bold>
</p>
        <p>Despite its proven efficacy in the management of moderately advanced laryngeal cancer, chemoradiotherapy has a high rate of highly debilitating side effects and complications.&#x000a0;Most commonly, patients will have complaints of xerostomia, mucositis, pain, and swallowing difficulty. These may manifest&#x000a0;as&#x000a0;late toxicity, resulting in gastrostomy support for nutritional intake in 13&#x000a0;to 14% of patients 1 to 2 years post-treatment.<xref ref-type="bibr" rid="article-22299.r51">[51]</xref><xref ref-type="bibr" rid="article-22299.r52">[52]</xref>&#x000a0;Scarring, edema, and stenosis may also occur within the upper aerodigestive tract, necessitating recurrent endoscopic dilatation of pharyngeal strictures&#x000a0;or tracheostomy in narrowed airways.<xref ref-type="bibr" rid="article-22299.r52">[52]</xref>&#x000a0;In the long term; depression, pain,&#x000a0;dysphagia, and&#x000a0;speech issues may have a significant effect on a patient's quality of life.<xref ref-type="bibr" rid="article-22299.r53">[53]</xref>&#x000a0;Further exacerbation of the rate of complications may occur due to numerous factors including advanced&#x000a0;age&#x000a0;and T-stage, site of primary disease, and neck dissection following oncological treatment.<xref ref-type="bibr" rid="article-22299.r51">[51]</xref></p>
        <p>
<bold>Complications of Surgery</bold>
</p>
        <p>Complications following transoral laser surgery are not infrequent, but are often minor and result in minimal morbidity for a patient. These can include local infection and bleeding, perforation and surgical emphysema, cutaneous fistula, dyspnoea, swallowing difficulties, and aspiration pneumonia.<xref ref-type="bibr" rid="article-22299.r54">[54]</xref>&#x000a0;Although uncommon, airway fires are a potentially devastating intra-operative complication of TLM, with potential sources of ignition, including the electrosurgical diathermy unit, light cords, and the CO2 laser.<xref ref-type="bibr" rid="article-22299.r55">[55]</xref></p>
        <p>In more advanced cases, laryngectomy has a&#x000a0;high rate of postoperative complications, with this rising further in salvage cases in previously irradiated patients. Pharyngocutaneous fistula remains one of the most common and challenging postoperative complications, frequently prolonging inpatient stay and delaying a return to an oral diet. Other potential complications include localized wound and lower respiratory tract infections, bleeding, damage to nerves (including the accessory, marginal mandibular and hypoglossal), and embolism.<xref ref-type="bibr" rid="article-22299.r56">[56]</xref><xref ref-type="bibr" rid="article-22299.r57">[57]</xref>&#x000a0;Moreover, the long term quality of life impacts of a laryngectomy can be considerable, as patients have to re-adapt to even the most basic functions of eating, breathing, and speaking.<xref ref-type="bibr" rid="article-22299.r57">[57]</xref></p>
      </sec>
      <sec id="article-22299.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Management of glottic tumors requires the support of an interprofessional team. This team includes the following specialties:</p>
        <list list-type="bullet">
          <list-item>
            <p>Otolaryngologists</p>
          </list-item>
          <list-item>
            <p>Maxillofacial and plastic surgeons</p>
          </list-item>
          <list-item>
            <p>Oncologists</p>
          </list-item>
          <list-item>
            <p>Radiologists</p>
          </list-item>
          <list-item>
            <p>Restorative dentists/oral surgeons</p>
          </list-item>
          <list-item>
            <p>Clinical nurse specialists</p>
          </list-item>
          <list-item>
            <p>Dieticians</p>
          </list-item>
          <list-item>
            <p>Speech and language&#x000a0;therapists</p>
          </list-item>
          <list-item>
            <p>Palliative care</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22299.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Excessive alcohol consumption and cigarette smoking&#x000a0;are intrinsic to the development of glottic cancers, with the continuation of smoking resulting in poorer functional outcomes, reduced survival, and a higher rate of recurrence. Moreover, cessation of smoking after 1&#x000a0;to 4 years can result in a significant risk reduction in developing laryngeal cancer, reaching the level of never-smokers after 20 years.<xref ref-type="bibr" rid="article-22299.r58">[58]</xref></p>
      </sec>
      <sec id="article-22299.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The variance in surgical and oncological management of glottic cancer across TNM stages highlights the importance of&#x000a0;the&#x000a0;multidisciplinary team. Invariably, there is an importance in performing an initial&#x000a0;outpatient history and examination by an otolaryngologist.&#x000a0;Subsequent initial investigations, including cross-sectional imaging and biopsy,&#x000a0;radiologists, and pathologists, are essential in achieving&#x000a0;definitive diagnosis and staging. Depending on the required treatment, otolaryngologists, and oncologists with a specialist interest in&#x000a0;head and neck, cancer&#x000a0;will be responsible for the provision of surgical, chemotherapy, and radiotherapy interventions. Given the myriad of complications and the often life-changing nature of these treatments, early involvement of associated specialists such as speech and language therapists, nurse specialists, dieticians&#x000a0;and psychologists are essential in maintaining patients' quality of life and providing a patient-centered care approach.</p>
      </sec>
      <sec id="article-22299.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22299&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22299">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/glottic-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22299">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22299/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22299">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22299.s17">
        <fig id="article-22299.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tumor and Nodal Staging of Laryngeal Cancer Contributed by A Koroulakis, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table__1__2__and__3__Cancerx__Laryngeal" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22299.s18">
        <fig id="article-22299.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Laryngeal Cancer Contributed by S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="laryngeal__cancer" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22299.s19">
        <title>References</title>
        <ref id="article-22299.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuper</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Adami</surname>
                <given-names>HO</given-names>
              </name>
            </person-group>
            <article-title>Tobacco use and cancer causation: association by tumour type.</article-title>
            <source>J Intern Med</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>252</volume>
            <issue>3</issue>
            <fpage>206</fpage>
            <page-range>206-24</page-range>
            <pub-id pub-id-type="pmid">12270001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gallus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bertuzzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Talamini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers.</article-title>
            <source>Br J Cancer</source>
            <year>2002</year>
            <month>Aug</month>
            <day>27</day>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>516</fpage>
            <page-range>516-8</page-range>
            <pub-id pub-id-type="pmid">12189548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Imhoff</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kranenburg</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Macco</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nijman</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>van Overbeeke</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wegner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Grolman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pothen</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review.</article-title>
            <source>Head Neck</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>38 Suppl 1</volume>
            <fpage>E2214</fpage>
            <page-range>E2214-20</page-range>
            <pub-id pub-id-type="pmid">25900211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis.</article-title>
            <source>Acta Otolaryngol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>134</volume>
            <issue>10</issue>
            <fpage>982</fpage>
            <page-range>982-9</page-range>
            <pub-id pub-id-type="pmid">25131391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Corsten</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Balram</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Johnson-Obaseki</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Does Socioeconomic Status Affect Stage at Presentation for Larynx Cancer in Canada's Universal Health Care System?</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>160</volume>
            <issue>3</issue>
            <fpage>488</fpage>
            <page-range>488-493</page-range>
            <pub-id pub-id-type="pmid">30200820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamangar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shakeri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malekzadeh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Islami</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Opium use: an emerging risk factor for cancer?</article-title>
            <source>Lancet Oncol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>e69</fpage>
            <page-range>e69-77</page-range>
            <pub-id pub-id-type="pmid">24480557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perloy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maasland</surname>
                <given-names>DHE</given-names>
              </name>
              <name>
                <surname>van den Brandt</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schouten</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Intake of meat and fish and risk of head-neck cancer subtypes in the Netherlands Cohort Study.</article-title>
            <source>Cancer Causes Control</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>647</fpage>
            <page-range>647-656</page-range>
            <pub-id pub-id-type="pmid">28382514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paget-Bailly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cyr</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Luce</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposures and cancer of the larynx-systematic review and meta-analysis.</article-title>
            <source>J Occup Environ Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-84</page-range>
            <pub-id pub-id-type="pmid">22157731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garavello</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lucenteforte</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bosetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Talamini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tavani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Diet diversity and the risk of laryngeal cancer: a case-control study from Italy and Switzerland.</article-title>
            <source>Oral Oncol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">18487075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gama</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Longatto Filho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scorsato</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Rautava</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Syrj&#x000e4;nen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Syrj&#x000e4;nen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis.</article-title>
            <source>Laryngoscope</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>885</fpage>
            <page-range>885-93</page-range>
            <pub-id pub-id-type="pmid">26542064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ndiaye</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alemany</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Castellsagu&#x000e9;</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Laporte</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Trottier</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.</article-title>
            <source>Lancet Oncol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>1319</fpage>
            <page-range>1319-31</page-range>
            <pub-id pub-id-type="pmid">25439690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rachet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Survival from cancer of the larynx in England and Wales up to 2001.</article-title>
            <source>Br J Cancer</source>
            <year>2008</year>
            <month>Sep</month>
            <day>23</day>
            <volume>99 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S35</fpage>
            <page-range>S35-7</page-range>
            <pub-id pub-id-type="pmid">18813254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.</article-title>
            <source>Laryngoscope</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>125</volume>
            <issue>7</issue>
            <fpage>1667</fpage>
            <page-range>1667-74</page-range>
            <pub-id pub-id-type="pmid">25694265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horny</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Kaiserling</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Involvement of the larynx by hemopoietic neoplasms. An investigation of autopsy cases and review of the literature.</article-title>
            <source>Pathol Res Pract</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>191</volume>
            <issue>2</issue>
            <fpage>130</fpage>
            <page-range>130-8</page-range>
            <pub-id pub-id-type="pmid">7567682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goudakos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Constantinidis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kostopoulos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vital</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nikolaou</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Primary laryngeal lymphoma: report of 3 cases and review of the literature.</article-title>
            <source>Head Neck</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>541</fpage>
            <page-range>541-9</page-range>
            <pub-id pub-id-type="pmid">19378323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Laryngeal chondrosarcoma: a 24-year experience at the Royal National Throat, Nose and Ear Hospital.</article-title>
            <source>Acta Otolaryngol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>120</volume>
            <issue>6</issue>
            <fpage>680</fpage>
            <page-range>680-8</page-range>
            <pub-id pub-id-type="pmid">11099143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases.</article-title>
            <source>J Exp Clin Cancer Res</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-30</page-range>
            <pub-id pub-id-type="pmid">15053292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damiani</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Damiani</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Hauck</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hyams</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid-adenosquamous carcinoma of the larynx and hypopharynx: a report of 21 cases and a review of the literature.</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>1981</year>
            <season>Mar-Apr</season>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-43</page-range>
            <pub-id pub-id-type="pmid">6787518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stachler</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Damask</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Digoy</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Krouse</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ouellette</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Reavis</surname>
                <given-names>CCW</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strode</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nnacheta</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>158</volume>
            <issue>1_suppl</issue>
            <fpage>S1</fpage>
            <page-range>S1-S42</page-range>
            <pub-id pub-id-type="pmid">29494321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tikka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pracy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paleri</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Refining the head and neck cancer referral guidelines: a two centre analysis of 4715 referrals.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-50</page-range>
            <pub-id pub-id-type="pmid">26857792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis-Jones</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Colley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.</article-title>
            <source>J Laryngol Otol</source>
            <year>2016</year>
            <month>May</month>
            <volume>130</volume>
            <issue>S2</issue>
            <fpage>S28</fpage>
            <page-range>S28-S31</page-range>
            <pub-id pub-id-type="pmid">27841111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zb&#x000e4;ren</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Casselman</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kohler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dulguerov</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging.</article-title>
            <source>Radiology</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>249</volume>
            <issue>2</issue>
            <fpage>551</fpage>
            <page-range>551-9</page-range>
            <pub-id pub-id-type="pmid">18936314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>McConkey</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hartley</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Nutting</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Al-Booz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Junor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rizwanullah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Zeidler</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Wieshmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hulme</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>J</given-names>
              </name>
              <collab>PET-NECK Trial Management Group</collab>
            </person-group>
            <article-title>PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Apr</month>
            <day>14</day>
            <volume>374</volume>
            <issue>15</issue>
            <fpage>1444</fpage>
            <page-range>1444-54</page-range>
            <pub-id pub-id-type="pmid">27007578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walker</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Wichman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Coster</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Impact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients.</article-title>
            <source>Pract Radiat Oncol</source>
            <year>2011</year>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-148</page-range>
            <pub-id pub-id-type="pmid">21857887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chudasama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Loughran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McKenzie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wight</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dey</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Dec</month>
            <day>12</day>
            <volume>2014</volume>
            <issue>12</issue>
            <fpage>CD002027</fpage>
            <pub-id pub-id-type="pmid">25503538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartl</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Brasnu</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Surgical Management of Early Glottic Cancer.</article-title>
            <source>Otolaryngol Clin North Am</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>611</fpage>
            <page-range>611-25</page-range>
            <pub-id pub-id-type="pmid">26233790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steuer</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>El-Deiry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Saba</surname>
                <given-names>NF</given-names>
              </name>
            </person-group>
            <article-title>An update on larynx cancer.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-50</page-range>
            <pub-id pub-id-type="pmid">27898173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lam</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>Tumor clearance at resection margins in total laryngectomy. A clinicopathologic study.</article-title>
            <source>Cancer</source>
            <year>1988</year>
            <month>Jun</month>
            <day>01</day>
            <volume>61</volume>
            <issue>11</issue>
            <fpage>2260</fpage>
            <page-range>2260-72</page-range>
            <pub-id pub-id-type="pmid">3365654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>De</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foran</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Harrington</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mortimore</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.</article-title>
            <source>J Laryngol Otol</source>
            <year>2016</year>
            <month>May</month>
            <volume>130</volume>
            <issue>S2</issue>
            <fpage>S75</fpage>
            <page-range>S75-S82</page-range>
            <pub-id pub-id-type="pmid">27841116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nishiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koizumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chatani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2006</year>
            <month>Jan</month>
            <day>01</day>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">16169681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Bentzen</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Emami</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2014</year>
            <month>Aug</month>
            <day>01</day>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>958</fpage>
            <page-range>958-963</page-range>
            <pub-id pub-id-type="pmid">25035199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le</surname>
                <given-names>QT</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Quivey</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Meyler</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Krieg</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1997</year>
            <month>Aug</month>
            <day>01</day>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-26</page-range>
            <pub-id pub-id-type="pmid">9300746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinshuck</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Shenoy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Voice outcomes for early laryngeal cancer.</article-title>
            <source>Curr Opin Otolaryngol Head Neck Surg</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-216</page-range>
            <pub-id pub-id-type="pmid">28277333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Drinnan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Natesh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paleri</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature.</article-title>
            <source>Cancer Treat Rev</source>
            <year>2012</year>
            <month>May</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-11</page-range>
            <pub-id pub-id-type="pmid">21764220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paleri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Basavaiah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Drinnan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mehanna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature.</article-title>
            <source>Cancer</source>
            <year>2011</year>
            <month>Jun</month>
            <day>15</day>
            <volume>117</volume>
            <issue>12</issue>
            <fpage>2668</fpage>
            <page-range>2668-76</page-range>
            <pub-id pub-id-type="pmid">21287526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laccourreye</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Laccourreye</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brasnu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>99</volume>
            <issue>6 Pt 1</issue>
            <fpage>421</fpage>
            <page-range>421-6</page-range>
            <pub-id pub-id-type="pmid">2350125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Department of Veterans Affairs Laryngeal Cancer Study Group</collab>
              <name>
                <surname>Wolf</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Hillman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Spaulding</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laramore</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Endicott</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>McClatchey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>Jun</month>
            <day>13</day>
            <volume>324</volume>
            <issue>24</issue>
            <fpage>1685</fpage>
            <page-range>1685-90</page-range>
            <pub-id pub-id-type="pmid">2034244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forastiere</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Goepfert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pajak</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Glisson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Trotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Leaf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ensley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Nov</month>
            <day>27</day>
            <volume>349</volume>
            <issue>22</issue>
            <fpage>2091</fpage>
            <page-range>2091-8</page-range>
            <pub-id pub-id-type="pmid">14645636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forastiere</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Maor</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Goepfert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pajak</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Glisson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Trotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Thorstad</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ensley</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2013</year>
            <month>Mar</month>
            <day>01</day>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>845</fpage>
            <page-range>845-52</page-range>
            <pub-id pub-id-type="pmid">23182993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grover</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Swisher-McClure</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Lukens</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Chalian</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>O'Malley</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2015</year>
            <month>Jul</month>
            <day>01</day>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>594</fpage>
            <page-range>594-601</page-range>
            <pub-id pub-id-type="pmid">26068492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Halpern</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Factors predictive of survival in advanced laryngeal cancer.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>133</volume>
            <issue>12</issue>
            <fpage>1270</fpage>
            <page-range>1270-6</page-range>
            <pub-id pub-id-type="pmid">18086971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Domenge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ozsahin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matuszewska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lef&#x000e8;bvre</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Greiner</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Giralt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maingon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rolland</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bolla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cognetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bourhis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirkpatrick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Glabbeke</surname>
                <given-names>M</given-names>
              </name>
              <collab>European Organization for Research and Treatment of Cancer Trial 22931</collab>
            </person-group>
            <article-title>Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>May</month>
            <day>06</day>
            <volume>350</volume>
            <issue>19</issue>
            <fpage>1945</fpage>
            <page-range>1945-52</page-range>
            <pub-id pub-id-type="pmid">15128894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pajak</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Forastiere</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Saxman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kish</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Cmelak</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Rotman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Machtay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ensley</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>KK</given-names>
              </name>
              <collab>Radiation Therapy Oncology Group 9501/Intergroup</collab>
            </person-group>
            <article-title>Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>May</month>
            <day>06</day>
            <volume>350</volume>
            <issue>19</issue>
            <fpage>1937</fpage>
            <page-range>1937-44</page-range>
            <pub-id pub-id-type="pmid">15128893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alpert</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Morbidini-Gaffney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Bogart</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kellman</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer.</article-title>
            <source>Cancer J</source>
            <year>2004</year>
            <season>Nov-Dec</season>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>335</fpage>
            <page-range>335-8</page-range>
            <pub-id pub-id-type="pmid">15701263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forest</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Nguyen-Tan</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Tabet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Larochelle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fortin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x000e9;linas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Souli&#x000e8;res</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Charpentier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guertin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma.</article-title>
            <source>Head Neck</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1099</fpage>
            <page-range>1099-105</page-range>
            <pub-id pub-id-type="pmid">16933313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Macann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McClure</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rischin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02.</article-title>
            <source>Head Neck</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-42</page-range>
            <pub-id pub-id-type="pmid">18286488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamoir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanin</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Thariat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weynand</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Machiels</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gr&#x000e9;goire</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Strojan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Takes</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.</article-title>
            <source>Oral Oncol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-10</page-range>
            <pub-id pub-id-type="pmid">22104248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lydiatt</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandwein</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Migliacci</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-137</page-range>
            <pub-id pub-id-type="pmid">28128848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stankovi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Milisavljevi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stojanov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zivi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zivaljevi&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stankovi&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Petrovi&#x00107;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer.</article-title>
            <source>Coll Antropol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>36 Suppl 2</volume>
            <fpage>7</fpage>
            <page-range>7-12</page-range>
            <pub-id pub-id-type="pmid">23397747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cosetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Schantz</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Five-year survival rates and time trends of laryngeal cancer in the US population.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>134</volume>
            <issue>4</issue>
            <fpage>370</fpage>
            <page-range>370-9</page-range>
            <pub-id pub-id-type="pmid">18427002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machtay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moughan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garden</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Forastiere</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.</article-title>
            <source>J Clin Oncol</source>
            <year>2008</year>
            <month>Jul</month>
            <day>20</day>
            <volume>26</volume>
            <issue>21</issue>
            <fpage>3582</fpage>
            <page-range>3582-9</page-range>
            <pub-id pub-id-type="pmid">18559875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Neill</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Atoria</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Baxi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Henman</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ganly</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Elkin</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Treatment complications and survival in advanced laryngeal cancer: a population-based analysis.</article-title>
            <source>Laryngoscope</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>12</issue>
            <fpage>2707</fpage>
            <page-range>2707-13</page-range>
            <pub-id pub-id-type="pmid">24577936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Sallah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karlsson</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Antoine</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues.</article-title>
            <source>Cancer</source>
            <year>2002</year>
            <month>Feb</month>
            <day>15</day>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>1131</fpage>
            <page-range>1131-41</page-range>
            <pub-id pub-id-type="pmid">11920484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vilaseca-Gonz&#x000e1;lez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bernal-Sprekelsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanch-Alejandro</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Moragas-Lluis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx.</article-title>
            <source>Head Neck</source>
            <year>2003</year>
            <month>May</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>382</fpage>
            <page-range>382-8</page-range>
            <pub-id pub-id-type="pmid">12692875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Operating room fires in otolaryngology: risk factors and prevention.</article-title>
            <source>Am J Otolaryngol</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-14</page-range>
            <pub-id pub-id-type="pmid">20392535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herranz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sarandeses</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Barro</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Vidal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gavil&#x000e1;n</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Complications after total laryngectomy in nonradiated laryngeal and hypopharyngeal carcinomas.</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>122</volume>
            <issue>6</issue>
            <fpage>892</fpage>
            <page-range>892-8</page-range>
            <pub-id pub-id-type="pmid">10828805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodard</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Oplatek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petruzzelli</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Life after total laryngectomy: a measure of long-term survival, function, and quality of life.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>526</fpage>
            <page-range>526-32</page-range>
            <pub-id pub-id-type="pmid">17576901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22299.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marron</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>ZF</given-names>
              </name>
              <name>
                <surname>Zaridze</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>W&#x000fc;nsch-Filho</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Winn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Talamini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Szeszenia-Dabrowska</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sturgis</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rudnai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Purdue</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Olshan</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Eluf-Neto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muscat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McClean</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mates</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Lissowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koifman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Herrero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fabianova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Daudt</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Dal Maso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Curado</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Cadoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Castellsague</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Boccia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Benhamou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Berthiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hashibe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk.</article-title>
            <source>Int J Epidemiol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>182</fpage>
            <page-range>182-96</page-range>
            <pub-id pub-id-type="pmid">19805488</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
